Oncology Commercial Assessment

December 19, 2019 Leah Hoffmann

The head of commercial development at a global biopharma giant was assessing the outlook for several oncology indications in key Asian markets. The team had already secured secondary research sources, and it had contracted with external agencies to conduct primary research. However, there was no one who could drive the analysis and create a comprehensive commercial assessment.

Business Talent Group delivered a senior life science leader who’d previously worked in BCG’s healthcare practice and headed Sanofi’s oncology strategy division. Experienced, pragmatic, and not afraid to dive into a complex landscape of treatment options and unmet medical needs, he helped the client synthesize data and size market opportunities. The client then used this analysis to finalize broader market strategies.

About the Author

Leah Hoffmann

Leah Hoffmann is a former journalist who has worked for Forbes.com and The Economist. She is passionate about clear thinking, sharp writing, and strong points of view.

More Content by Leah Hoffmann
Previous Article
Pharma Product Launch Best Practices
Pharma Product Launch Best Practices

Independent biopharma marketer Kimberly Crichton explains how technology is changing the way life science c...

Next Article
Accelerating Pharma Product Launch: A Q&A With Ron Niesen
Accelerating Pharma Product Launch: A Q&A With Ron Niesen

Life Science project leader Ron Niesen discusses pharma product launch best practices, from gathering data ...

Get our free guide to working with on-demand talent.

Read Now